Literature DB >> 15313557

Regulation of chemokine-induced lymphocyte migration by RGS proteins.

Chantal Moratz1, Kathleen Harrison, John H Kehrl.   

Abstract

G-protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by inducing the G-protein alpha (Galpha) subunit to exchange guanosine diphosphate for guanosine triphosphate. Regulators of G-protein signaling (RGS) proteins enhance the deactivation of Galpha subunits, thereby reducing the activation of downstream effectors. Several members of the RGS family are expressed in lymphocytes. Among RGS proteins with the highest levels of expression are RGS1, RGS2, RGS10, RGS13, RGS14, RGS16, and RGS19. Perhaps the most important G-protein-coupled receptors in lymphocytes potentially subject to regulation by RGS proteins are the chemokine receptors. By signaling through these receptors, chemokines help orchestrate immune cell trafficking both during the development of the immune system and during responses to exogenous or infectious agents. Thus, the level and regulation of RGS proteins in lymphocytes likely significantly impact lymphocyte migration and function. This article provides some tools for the analysis of RGS protein expression in lymphocytes and outlines a number of methods for the analysis of the effects of RGS proteins on lymphocyte migration and chemokine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313557     DOI: 10.1016/S0076-6879(04)89002-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  26 in total

1.  Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?

Authors:  Tuba Sevimoglu; Kazim Yalcin Arga
Journal:  OMICS       Date:  2015-10-19

2.  Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele.

Authors:  Xinyan Huang; Ying Fu; Raelene A Charbeneau; Thomas L Saunders; Douglas K Taylor; Kurt D Hankenson; Mark W Russell; Louis G D'Alecy; Richard R Neubig
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

4.  Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Jae-Kyung Lee; Josephine Bou Dagher
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

Review 5.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

Review 6.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

7.  Adipose tissue RNASeq reveals novel gene-nutrient interactions following n-3 PUFA supplementation and evoked inflammation in humans.

Authors:  Jane F Ferguson; Chenyi Xue; Yu Hu; Mingyao Li; Muredach P Reilly
Journal:  J Nutr Biochem       Date:  2016-01-11       Impact factor: 6.048

8.  Integrative meta-analysis of differential gene expression in acute myeloid leukemia.

Authors:  Brady G Miller; John A Stamatoyannopoulos
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

9.  Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3).

Authors:  Melissa Branham-O'Connor; William G Robichaux; Xian-Kui Zhang; Hyeseon Cho; John H Kehrl; Stephen M Lanier; Joe B Blumer
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

10.  PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis.

Authors:  Grant D Barish; Annette R Atkins; Michael Downes; Peter Olson; Ling-Wa Chong; Mike Nelson; Yuhua Zou; Hoosang Hwang; Heonjoong Kang; Linda Curtiss; Ronald M Evans; Chih-Hao Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.